D-0339-2019 Class II Terminated
FDA drug recall D-0339-2019 was initiated by Pfizer Inc. on Dec 6, 2018 and is designated Class II. Reason for recall: Superpotent Drug. The recall status is terminated (terminated Oct 8, 2020). Affected quantity: 1996 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Dec 26, 2018
- Initiation Date
- Dec 6, 2018
- Termination Date
- Oct 8, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1996 bottles
Product Description
Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. New York, NY 10017, NDC 60793-855-01
Reason for Recall
Superpotent Drug.
Distribution Pattern
Nationwide within the United States
Code Information
Lot #:18A18, Exp. 01/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0339-2019
- openFDA file date
- Oct 21, 2026
- Loaded by RegDataLab
- Oct 23, 2026